IBOK
GSK icon

Independence Bank of Kentucky’s GSK GSK Stock Holding History

Independence Bank of Kentucky’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.6K Hold
1,347
– – 0.01% 374
2026
Q1 		$74.3K Sell
1,347
-52
-4% -$2.82K 0.01% 373
2025
Q4 		$68.6K Buy
1,399
+52
+4% +$2.42K 0.01% 392
2025
Q3 		$58.1K Sell
1,347
-360
-21% -$14.1K 0.01% 401
2025
Q2 		$65.5K Buy
1,707
+138
+9% +$5.27K 0.01% 381
2025
Q1 		$60.8K Hold
1,569
– – 0.01% 381
2024
Q4 		$53.1K Sell
1,569
-1,072
-41% -$38.6K 0.01% 386
2024
Q3 		$108K Sell
2,641
-966
-27% -$39.5K 0.02% 320
2024
Q2 		$139K Sell
3,607
-2,424
-40% -$102K 0.04% 270
2024
Q1 		$259K Sell
6,031
-4,277
-41% -$176K 0.08% 198
2023
Q4 		$382K Sell
10,308
-3,815
-27% -$137K 0.13% 153
2023
Q3 		$512K Sell
14,123
-6,355
-31% -$226K 0.22% 109
2023
Q2 		$730K Sell
20,478
-2,223
-10% -$79.7K 0.3% 84
2023
Q1 		$808K Buy
22,701
+115
+0.5% +$4.02K 0.35% 79
2022
Q4 		$794K Buy
+22,586
New +$752K 0.36% 82
2022
Q3 		– Sell
-19,950
Closed -$1.09M – 423
2022
Q2 		$1.09M Sell
19,950
-228
-1% -$12.6K 0.49% 63
2022
Q1 		$1.1M Sell
20,178
-360
-2% -$19.6K 0.44% 68
2021
Q4 		$1.13M Sell
20,538
-4,197
-17% -$218K 0.46% 63
2021
Q3 		$1.18M Sell
24,735
-2,616
-10% -$131K 0.51% 57
2021
Q2 		$1.36M Buy
27,351
+2,740
+11% +$132K 0.6% 50
2021
Q1 		$1.1M Sell
24,611
-5,656
-19% -$257K 0.53% 58
2020
Q4 		$1.39M Buy
30,267
+2,850
+10% +$131K 0.72% 44
2020
Q3 		$1.29M Buy
27,417
+3,917
+17% +$196K 0.73% 46
2020
Q2 		$1.2M Buy
23,500
+1,952
+9% +$100K 0.78% 43
2020
Q1 		$1.02M Buy
21,548
+8,048
+60% +$429K 0.8% 38
2019
Q4 		$793K Buy
13,500
+28
+0.2% +$1.56K 0.51% 57
2019
Q3 		$719K Sell
13,472
-220
-2% -$11.3K 0.51% 55
2019
Q2 		$685K Sell
13,692
-4,684
-25% -$235K 0.54% 52
2019
Q1 		$960K Sell
18,376
-4,662
-20% -$233K 0.79% 41
2018
Q4 		$1.1M Buy
23,038
+1,108
+5% +$54.6K 1% 34
2018
Q3 		$1.1M Sell
21,930
-492
-2% -$25K 0.87% 39
2018
Q2 		$1.13M Buy
22,422
+452
+2% +$22.8K 0.95% 37
2018
Q1 		$1.07M Buy
21,970
+2,048
+10% +$95.4K 0.91% 38
2017
Q4 		$883K Buy
+19,922
New +$920K 0.75% 41

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Independence Bank of Kentucky's GSK Position: Q2 2026 in Review

Independence Bank of Kentucky held its GSK (GSK) position steady in Q2 2026 at 1,347 shares worth $70.6K. The position accounts for 0.01% of the portfolio, ranked #374.

Independence Bank of Kentucky first reported a position in GSK in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.39M in Q4 2020. 492 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Independence Bank of Kentucky held 1,347 shares of GSK worth $70.6K as of Q2 2026.
  • Independence Bank of Kentucky left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #374 holding.
  • Independence Bank of Kentucky first reported a position in GSK in Q4 2017 and has held it in 34 quarters since.
  • Independence Bank of Kentucky's GSK position peaked at $1.39M in Q4 2020.
  • 492 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.